Primary Causes & Action Plans
hs-CRP
Systemic inflammation driven by endometriotic tissueSuggested Action Plan
Lower hs-CRP through Mediterranean diet, omega-3 supplementation (3000-5000 mg EPA/DHA daily), regular exercise, stress management. Retest every 2-3 months to monitor disease activity.
CA-125
Tumor marker associated with endometrial proliferation; elevated in endometriosisSuggested Action Plan
CA-125 is not specific to endometriosis but tracks disease burden. Monitor alongside hs-CRP. Retest every 3-6 months during treatment.
Estradiol
Endometriotic lesions produce excess estrogen locally; high estradiol drives proliferationSuggested Action Plan
Suppress estradiol through low-glycemic diet, exercise, weight loss. Aromatase inhibitors (letrozole) may be used off-label to suppress estradiol in severe cases. Work with gynecologist on dose.
Iron and Ferritin
Iron accumulation in endometriotic lesions and peritoneal fluid drives oxidative stressSuggested Action Plan
Avoid iron supplementation unless specifically deficient. High-dose iron supplementation may worsen endometriosis. Chelate iron through regular blood donation if ferritin is elevated.
Vitamin D
Critical for immune tolerance and reducing ectopic endometrial growthSuggested Action Plan
If deficient, supplement vitamin D3 4000-5000 IU daily. Target 60-80 ng/mL for endometriosis management. Retest in 8-12 weeks.